A deleterious BRCA1 mutation in a young Pakistani woman with metaplastic breast carcinoma

Pathol Res Pract. 2011 Sep 15;207(9):583-6. doi: 10.1016/j.prp.2011.05.011. Epub 2011 Jun 30.

Abstract

Metaplastic breast carcinoma (MBC) is a relatively rare subtype of breast cancer that encompasses a pathologically heterogeneous group of tumors. Pathogenic germ line mutations in the major breast cancer susceptibility genes BRCA1 and BRCA2 genes have been rarely found or described in MBC. We report the identification of the BRCA1 185delAG mutation in a 22-year-old Pakistani woman with triple-negative MBC that showed biphasic morphological features, including sarcomatous and malignant epithelial components. A comprehensive description of the clinical, histopathological, morphological, and immunohistochemical features of the tumor and the patient's treatment course is presented.

Publication types

  • Case Reports

MeSH terms

  • BRCA1 Protein / genetics*
  • BRCA1 Protein / metabolism
  • Biomarkers, Tumor / metabolism
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy
  • Carcinoma, Ductal, Breast / genetics
  • Carcinoma, Ductal, Breast / metabolism
  • Carcinoma, Ductal, Breast / pathology*
  • Carcinoma, Ductal, Breast / therapy
  • Combined Modality Therapy
  • Disease-Free Survival
  • Female
  • Germ-Line Mutation*
  • Humans
  • Mastectomy, Modified Radical
  • Metaplasia
  • Sarcoma / genetics
  • Sarcoma / metabolism
  • Sarcoma / pathology*
  • Sarcoma / therapy
  • Treatment Outcome

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • Biomarkers, Tumor